Nano-ImmunoEra Project

The next generation detection

Research, training and collaborative objects

Nano-ImmunoEra is a research and innovation staff exchange network aiming at the development of innovative biosensors and diagnostic tools for the detection of clinically relevant antibodies.

Nano-ImmunoEra will form the next generation of clinically-oriented analytical scientists capable of delivering innovative solutions that will improve the lives of patients, reduce the cost of healthcare and position Europe as a leader in biomedical devices.

Project ambition

The future of molecular diagnostics

Our aim is to develop, optimize, and assess novel molecular diagnostic platforms with a focus on cancer monitoring. Combining different nano- and microscale materials and devices, with antibody-responsive biomolecules serving as recognition elements.

The young international project

The proposed exchange program aims at boosting academic careers of young researchers, and at promoting a transfer of knowledge between Italy, USA, Spain, Germany, Switzerland, The Netherlands, and South Africa by building a multicultural team.

A strong intersectoral dimension

A key aspect of Nano-ImmunoEra is its interdisciplinary nature to use a variety of approaches and strategies. The project brings together nucleic acid chemistry, molecular bioengineering, electrochemiluminescence and CRISPR-based technology.

Europe, research and careers

Our aim is to encourage the mobility of researchers in Europe and to boost the careers of European researchers. It is essential to make Europe attractive again to the rest of the world by giving young people a taste for research and scientific careers.

Latest News

Stay updated on the Eclipse project and the latest publications.

newsevents

1 February 2023

Nano-ImmunoEra Kick-off Meeting

Feb 1st, 2023. kick-off meeting for the MSCA Staff…

All the news

United in research. This is our international team

To deliver these goals, we have assembled a highly inter- and multidisciplinary and multicultural team of European as well as strategic non-EU Countries through the collaboration among 7 academic institutions and 2 non-academic partners to enable ultimate impact to the healthcare.